Pliant Therapeutics, Inc. (PLRX) stock
PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.74−0.04 (-4.84%)
Close on Nov 12, 2026Market cap $45.82MP/E –Yield 0.00%
Pliant Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Pliant Therapeutics's enterprise value was -$109.95M on Nov 11, 2026, against -$142.86M a year earlier. Over the last 5 years it ranged from -$275.04M to $1.35B, with a median of $239.28M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$109.95M | – |
| 2025 | Dec 31, 2025 | -$166.83M | -142.2% |
| 2024 | Dec 31, 2024 | $395.39M | -29.5% |
| 2023 | Dec 29, 2023 | $561.01M | -3.6% |
| 2022 | Dec 30, 2022 | $582.09M | +119.9% |
| 2021 | Dec 31, 2021 | $264.65M | -48.3% |
| 2020 | Dec 31, 2020 | $511.78M | – |
See a number that looks wrong?